BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32102538)

  • 1. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
    Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
    Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
    Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
    Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
    Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
    Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
    World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma.
    Khairy A; Hamza I; Shaker O; Yosry A
    Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
    Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma.
    Shaker O; Alhelf M; Morcos G; Elsharkawy A
    Infect Genet Evol; 2017 Jul; 51():173-181. PubMed ID: 28366737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients.
    El-Araby RE; Khalifa MA; Zoheiry MM; Zahran MY; Rady MI; Ibrahim RA; El-Talkawy MD; Essawy FM
    Cancer Gene Ther; 2020 Jun; 27(6):486-497. PubMed ID: 31316135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C.
    Tsai YS; Yeh ML; Tsai PC; Huang CI; Huang CF; Hsieh MH; Liu TW; Lin YH; Liang PC; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.
    Hagag NA; Ali YBM; Elsharawy AA; Talaat RM
    J Gastrointest Cancer; 2020 Mar; 51(1):234-241. PubMed ID: 31028536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.